These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection. Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047 [TBL] [Abstract][Full Text] [Related]
25. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells. Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081 [TBL] [Abstract][Full Text] [Related]
26. T Cell Receptor Diversity and Lineage Relationship between Virus-Specific CD8 T Cell Subsets during Chronic Lymphocytic Choriomeningitis Virus Infection. Chang YM; Wieland A; Li ZR; Im SJ; McGuire DJ; Kissick HT; Antia R; Ahmed R J Virol; 2020 Sep; 94(20):. PubMed ID: 32759317 [TBL] [Abstract][Full Text] [Related]
27. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275 [TBL] [Abstract][Full Text] [Related]
28. A critical role for neutralizing-antibody-producing B cells, CD4(+) T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Planz O; Ehl S; Furrer E; Horvath E; Bründler MA; Hengartner H; Zinkernagel RM Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6874-9. PubMed ID: 9192659 [TBL] [Abstract][Full Text] [Related]
29. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection. Suresh M; Gao X; Fischer C; Miller NE; Tewari K J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models. Audigé A; Hofer U; Dittmer U; van den Broek M; Speck RF Viral Immunol; 2011 Oct; 24(5):375-85. PubMed ID: 21929334 [TBL] [Abstract][Full Text] [Related]
31. Chronic lymphocytic choriomeningitis virus infection actively down-regulates CD4+ T cell responses directed against a broad range of epitopes. Mothé BR; Stewart BS; Oseroff C; Bui HH; Stogiera S; Garcia Z; Dow C; Rodriguez-Carreno MP; Kotturi M; Pasquetto V; Botten J; Crotty S; Janssen E; Buchmeier MJ; Sette A J Immunol; 2007 Jul; 179(2):1058-67. PubMed ID: 17617598 [TBL] [Abstract][Full Text] [Related]
32. Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo. McCausland MM; Crotty S J Virol Methods; 2008 Jan; 147(1):167-76. PubMed ID: 17920702 [TBL] [Abstract][Full Text] [Related]
33. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM. von Herrath M; Holz A J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748 [TBL] [Abstract][Full Text] [Related]
34. Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720. Salinas NR; Lopes CT; Palma PV; Oshima CT; Bueno V Pathol Oncol Res; 2009 Dec; 15(4):549-54. PubMed ID: 19214784 [TBL] [Abstract][Full Text] [Related]
35. Host genetics play a critical role in controlling CD8 T cell function and lethal immunopathology during chronic viral infection. Christiaansen AF; Schmidt ME; Hartwig SM; Varga SM PLoS Pathog; 2017 Jul; 13(7):e1006498. PubMed ID: 28715493 [TBL] [Abstract][Full Text] [Related]
36. Bone marrow is a major site of long-term antibody production after acute viral infection. Slifka MK; Matloubian M; Ahmed R J Virol; 1995 Mar; 69(3):1895-902. PubMed ID: 7853531 [TBL] [Abstract][Full Text] [Related]
37. [A new therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)]. Chiba K Nihon Rinsho Meneki Gakkai Kaishi; 2009 Apr; 32(2):92-101. PubMed ID: 19404007 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of immunologic injury of cultured cells infected with lymphocytic choriomeningitis virus: role of defective interfering virus in regulating viral antigenic expression. Welsh RM; Oldstone MB J Exp Med; 1977 Jun; 145(6):1449-68. PubMed ID: 301173 [TBL] [Abstract][Full Text] [Related]
39. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. Homann D; Tishon A; Berger DP; Weigle WO; von Herrath MG; Oldstone MB J Virol; 1998 Nov; 72(11):9208-16. PubMed ID: 9765468 [TBL] [Abstract][Full Text] [Related]
40. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice. Holst PJ; Christensen JP; Thomsen AR J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]